Short answer · Medically reviewed summary · Last updated: 2026-05-08
Swyer Syndrome, also known as 46,XY complete gonadal dysgenesis, is characterized by the failure of gonads to develop into testes, resulting in individuals with a 46,XY karyotype who have a female phenotype. The most common clinical presentation includes primary amenorrhea (absence of menstruation) and a lack of secondary sexual characteristics during puberty, as the streak gonads do not produce sufficient sex hormones. What are the primary clinical features of Swyer Syndrome? Because individuals with Swyer Syndrome possess streak gonads rather than functional testes or ovaries, they do not undergo typical puberty.
Swyer Syndrome, also known as 46,XY complete gonadal dysgenesis, is characterized by the failure of gonads to develop into testes, resulting in individuals with a 46,XY karyotype who have a female phenotype. The most common clinical presentation includes primary amenorrhea (absence of menstruation) and a lack of secondary sexual characteristics during puberty, as the streak gonads do not produce sufficient sex hormones.
Because individuals with Swyer Syndrome possess streak gonads rather than functional testes or ovaries, they do not undergo typical puberty. The most common symptoms include:
The primary impact on quality of life for those with Swyer Syndrome stems from the hormonal imbalance and infertility. Because the streak gonads are non-functional, patients require hormone replacement therapy (HRT) to induce puberty and maintain bone density. Without intervention, these patients remain at risk for osteoporosis. Furthermore, individuals with Swyer Syndrome have a significant risk (approximately 20-30%) of developing gonadoblastoma in their streak gonads, which necessitates surgical removal (gonadectomy).
Families should consult a pediatric endocrinologist if a young person fails to show signs of puberty by age 13 or fails to menstruate by age 15. Early diagnosis of Swyer Syndrome is critical for managing long-term health, including the initiation of appropriate hormone therapy and the scheduling of prophylactic surgery to mitigate the risk of malignancy in the streak gonads.
Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider.